COVID-19合并sars-cov-2感染患者红细胞吞噬功能的研究

IF 0.6
I. Reva, Tatsuo Yamamoto, E. Slabenko, M. Fleishman, O. Lebedko, M. Tuchina, Viktoriya Semiglasova, Y. Krasnikov, V. Tolmachev, Y. Gainullina, G. Reva
{"title":"COVID-19合并sars-cov-2感染患者红细胞吞噬功能的研究","authors":"I. Reva, Tatsuo Yamamoto, E. Slabenko, M. Fleishman, O. Lebedko, M. Tuchina, Viktoriya Semiglasova, Y. Krasnikov, V. Tolmachev, Y. Gainullina, G. Reva","doi":"10.35630/2023/13/1.203","DOIUrl":null,"url":null,"abstract":"Red bone marrow samples investigation in deceased COVID-19 patients enabled to identify the phenomena of secondary hemophagocytosis. Analysis of the data showed that phagocytic reactions during infection of patients with SARS-CoV-2 are manifested both in relation to erythrocytes and leukocytes. The data obtained make it possible to expand the strategy of therapeutic measures, taking into account the new data on the mechanisms of the pathogenesis of COVID-19 in severe viral infection based on morphological findings and additional information on the involvement of young erythrocytes and lymphocytes in the structure of the red bone marrow in the cascade of pathological reactions. The results obtained confirm a wide range of aggressive damaging effects of SARS-CoV-2 in the development of multiple organ failure against the background of COVID-19 and the involvement of the red bone marrow in the pathological process. The authors supplemented information about the mechanisms of hypoxia in COVID-19, which is not only a consequence of damage to the respiratory epithelium, but also the result of damage to erythrocyte differons both at the level of red bone marrow and in peripheral blood. This fact must be taken into account in the development of a treatment strategy and in the creation of new drugs for the treatment of infected patients with various strains of SARS-CoV-2.","PeriodicalId":51770,"journal":{"name":"Archiv EuroMedica","volume":" ","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2023-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"HEMOPHAGOCYTOSIS IN THE RED BONE MARROW OF PATIENTS WITH COVID-19 WITH SARS-COV-2 INFECTION\",\"authors\":\"I. Reva, Tatsuo Yamamoto, E. Slabenko, M. Fleishman, O. Lebedko, M. Tuchina, Viktoriya Semiglasova, Y. Krasnikov, V. Tolmachev, Y. Gainullina, G. Reva\",\"doi\":\"10.35630/2023/13/1.203\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Red bone marrow samples investigation in deceased COVID-19 patients enabled to identify the phenomena of secondary hemophagocytosis. Analysis of the data showed that phagocytic reactions during infection of patients with SARS-CoV-2 are manifested both in relation to erythrocytes and leukocytes. The data obtained make it possible to expand the strategy of therapeutic measures, taking into account the new data on the mechanisms of the pathogenesis of COVID-19 in severe viral infection based on morphological findings and additional information on the involvement of young erythrocytes and lymphocytes in the structure of the red bone marrow in the cascade of pathological reactions. The results obtained confirm a wide range of aggressive damaging effects of SARS-CoV-2 in the development of multiple organ failure against the background of COVID-19 and the involvement of the red bone marrow in the pathological process. The authors supplemented information about the mechanisms of hypoxia in COVID-19, which is not only a consequence of damage to the respiratory epithelium, but also the result of damage to erythrocyte differons both at the level of red bone marrow and in peripheral blood. This fact must be taken into account in the development of a treatment strategy and in the creation of new drugs for the treatment of infected patients with various strains of SARS-CoV-2.\",\"PeriodicalId\":51770,\"journal\":{\"name\":\"Archiv EuroMedica\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2023-02-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archiv EuroMedica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35630/2023/13/1.203\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archiv EuroMedica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35630/2023/13/1.203","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

通过对COVID-19死亡患者的红骨髓样本调查,发现继发性噬血现象。数据分析表明,SARS-CoV-2患者感染过程中的吞噬反应既表现在红细胞方面,也表现在白细胞方面。所获得的数据使扩大治疗措施的策略成为可能,考虑到基于形态学发现的COVID-19在严重病毒感染中的发病机制的新数据,以及在病理反应级联中红骨髓结构中年轻红细胞和淋巴细胞参与的额外信息。这些结果证实了SARS-CoV-2在COVID-19背景下多器官衰竭的发展中具有广泛的侵袭性损伤作用,并且在病理过程中参与了红骨髓。作者补充了关于COVID-19缺氧机制的信息,这不仅是呼吸上皮损伤的结果,也是红骨髓和外周血水平红细胞差异损伤的结果。在制定治疗战略和开发治疗各种SARS-CoV-2病毒株感染患者的新药时,必须考虑到这一事实。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
HEMOPHAGOCYTOSIS IN THE RED BONE MARROW OF PATIENTS WITH COVID-19 WITH SARS-COV-2 INFECTION
Red bone marrow samples investigation in deceased COVID-19 patients enabled to identify the phenomena of secondary hemophagocytosis. Analysis of the data showed that phagocytic reactions during infection of patients with SARS-CoV-2 are manifested both in relation to erythrocytes and leukocytes. The data obtained make it possible to expand the strategy of therapeutic measures, taking into account the new data on the mechanisms of the pathogenesis of COVID-19 in severe viral infection based on morphological findings and additional information on the involvement of young erythrocytes and lymphocytes in the structure of the red bone marrow in the cascade of pathological reactions. The results obtained confirm a wide range of aggressive damaging effects of SARS-CoV-2 in the development of multiple organ failure against the background of COVID-19 and the involvement of the red bone marrow in the pathological process. The authors supplemented information about the mechanisms of hypoxia in COVID-19, which is not only a consequence of damage to the respiratory epithelium, but also the result of damage to erythrocyte differons both at the level of red bone marrow and in peripheral blood. This fact must be taken into account in the development of a treatment strategy and in the creation of new drugs for the treatment of infected patients with various strains of SARS-CoV-2.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Archiv EuroMedica
Archiv EuroMedica MEDICINE, GENERAL & INTERNAL-
自引率
83.30%
发文量
140
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信